CLDX · CIK 0000744218 · FY2025 live · 2025-12-31
Celldex Therapeutics, Inc.
View as
Model
Classic Z
FY2025
0.68
Zone
Distress
Prior
—
Market DD
—
1y PD
—
0.68
Z″ 1.90
Score 0.68 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.831.2 × = 1.00X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−3.111.4 × = −4.36X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.493.3 × = −1.63X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
9.440.6 × = 5.67X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
33.55
0–100 · Classic Z family
Book standing
42
Year change
—
Market PD
—
O-score
11
Events on this name
Same published rows as Today.
No published events on this print.
Overview
rule-v1
Celldex Therapeutics, Inc. is on classic Z at 0.68 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print; retained earnings / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 63rd percentile in Healthcare.
- PTCTDistressPTC THERAPEUTICS, INC.0.65
- RLYBDistressRallybio Corp0.65
- ACOGDistressAlpha Cognition Inc.0.72
- IARTDistressINTEGRA LIFESCIENCES HOLDINGS CORP0.65
- SLSDistressSELLAS Life Sciences Group, Inc.0.63
- ONCDistressBeOne Medicines Ltd.0.74
- PRCTDistressPROCEPT BioRobotics Corp0.62
- MDWDDistressMediWound Ltd.0.61
Filing line items
Current assets
$535M
Total assets
$583M
Current liabilities
$51M
Total liabilities
$56M
Working capital
$484M
Retained earnings
−$1.8B
EBIT
−$287M
Total sales
$2M
Book equity
$527M
Accession 0001104659-26-019652. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.